Compile Data Set for Download or QSAR
Report error Found 91 Enz. Inhib. hit(s) with all data for entry = 11914
TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660540(US20240092802, Compound 52)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660551(US20240092802, Compound 64)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660550(US20240092802, Compound 63)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660549(US20240092802, Compound 62)
Affinity DataEC50: >2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660548(US20240092802, Compound 61)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660547(US20240092802, Compound 60)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660546(US20240092802, Compound 59)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660545(US20240092802, Compound 58)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660544(US20240092802, Compound 57)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660543(US20240092802, Compound 56)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660542(US20240092802, Compound 55)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660541(US20240092802, Compound 53)
Affinity DataEC50:  74.1nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660552(US20240092802, Compound 65)
Affinity DataEC50: >2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660539(US20240092802, Compound 51)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660538(US20240092802, Compound 50)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660537(US20240092802, Compound 49)
Affinity DataEC50:  137nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660536(US20240092802, Compound 48)
Affinity DataEC50:  15.2nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660535(US20240092802, Compound 47)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660534(US20240092802, Compound 46)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660533(US20240092802, Compound 45)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660533(US20240092802, Compound 45)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660532(US20240092802, Compound 44)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660532(US20240092802, Compound 44)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660563(US20240092802, Compound 76)
Affinity DataEC50:  145nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660572(US20240092802, Compound tianeptine)
Affinity DataEC50:  641nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660572(US20240092802, Compound tianeptine)
Affinity DataEC50:  194nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660571(US20240092802, Compound 84)
Affinity DataEC50:  40nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660570(US20240092802, Compound 83)
Affinity DataEC50:  1.81nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660569(US20240092802, Compound 82)
Affinity DataEC50:  122nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660568(US20240092802, Compound 81)
Affinity DataEC50:  573nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660567(US20240092802, Compound 80)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660567(US20240092802, Compound 80)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660566(US20240092802, Compound 79)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660565(US20240092802, Compound 78)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660564(US20240092802, Compound 77)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660531(US20240092802, Compound 43)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660562(US20240092802, Compound 75)
Affinity DataEC50: >2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660561(US20240092802, Compound 74)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660560(US20240092802, Compound 73)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660559(US20240092802, Compound 72)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660558(US20240092802, Compound 71)
Affinity DataEC50:  222nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660557(US20240092802, Compound 70)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660556(US20240092802, Compound 69)
Affinity DataEC50: <2.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660555(US20240092802, Compound 68)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660554(US20240092802, Compound 67)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660553(US20240092802, Compound 66)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660504(US20240092802, Compound 14)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660511(US20240092802, Compound 21)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Mouse)
Kures

US Patent
LigandPNGBDBM660510(US20240092802, Compound 20)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
Kures

US Patent
LigandPNGBDBM660510(US20240092802, Compound 20)
Affinity DataEC50: <1.00E+4nMAssay Description:Human or mouse MOR cDNA was transfected alongside GαoB with RLuc8 inserted at position 91 (GαoB-RLuc8), Gβ1 (β1), and Gγ2 fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: